Camilla Sylvest
Director/Board Member bij ARGENX SE
Vermogen: 88 962 $ op 31-03-2024
Profiel
Ms. Camilla Sylvest is an Independent Non-Executive Director at argenx SE, an EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk A/S, an Independent Director at Danish Crown A/S and a Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH.
She is on the Board of Directors at argenx SE, Danish Crown A/S and World Diabetes Foundation.
She received her graduate degree from the University of Southern Denmark and an MBA from Scandinavian International Management Institute.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ARGEN-X SE
0.00% | 20-02-2024 | 225 ( 0.00% ) | 88 962 $ | 31-03-2024 |
Actieve functies van Camilla Sylvest
Bedrijven | Functie | Begin |
---|---|---|
NOVO NORDISK A/S | Corporate Officer/Principal | 01-01-2003 |
ARGENX SE | Director/Board Member | 08-09-2022 |
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 18-10-2011 |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Director/Board Member | - |
World Diabetes Foundation | Director/Board Member | - |
Opleiding van Camilla Sylvest
University of Southern Denmark | Graduate Degree |
Scandinavian International Management Institute | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
ARGENX SE | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Consumer Non-Durables |
World Diabetes Foundation | Miscellaneous |